JaLCDOI 10.18926/AMO/31542
フルテキストURL fulltext.pdf
著者 Hayase, Ryoji| Eguchi, Katsuto| Sekiba, Kaoru|
抄録 <p>Polyamines are closely related to many aspects of cell growth. Since increased amounts of polyamines in the urine of human cancer patients were reported in 1971, polyamines have been studied from the standpoint of tumor markers. In this study, polyamines in erythrocytes, plasma and urine were determined in 42 controls and 105 patients with gynecologic malignant tumors. The changes in polyamine levels were investigated before and after treatment. With advances in the stage of uterine cervical cancer, the frequency of abnormal levels of polyamines (concentrations greater than two standard deviations above the mean control level) became greater, and reached nearly 80% in recurrent and ovarian cancer. In the early stage of cancer, the diagnostic value was low. Comparison with carcinoembryonic antigen (CEA) was also performed. The polyamines lack specificity for malignant diseases, but they can be used to some extent as a tumor marker in the gynecologic field.</p>
キーワード polyamine gynecologic malignancy high performance liquid chromatography tumor marker
Amo Type Article
発行日 1985-02
出版物タイトル Acta Medica Okayama
39巻
1号
出版者 Okayama University Medical School
開始ページ 35
終了ページ 45
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
論文のバージョン publisher
査読 有り
PubMed ID 3984779
Web of Sience KeyUT A1985ACS5600004
JaLCDOI 10.18926/AMO/31116
フルテキストURL fulltext.pdf
著者 Kodama, Junichi| Hayase, Ryoji| Yoshinouchi, Mitsuo| Okuda, Hiroyuki| Kudo, Takafumi|
抄録 <p>P-glycoprotein is a transmembrane protein which acts as an energy-dependent drug efflux pump for a variety of anti-cancer drugs. The mdr-1 gene which encodes P-glycoprotein was successfully cloned in 1986. To investigate P-glycoprotein expression in diverse ovarian tumors, including benign, low malignant potential and malignant, immunohistochemical study was done using a monoclonal antibody (C 219). Overall, 8 out of the 59 epithelial ovarian tumors (13.6%) expressed P-glycoprotein. It was noted that 5 of the 12 mucinous tumors were found to express P-glycoprotein, while none of the 31 serous tumors were immunohistochemically positive. In 10 malignant ovarian tumors, P-glycoprotein immunostaining was examined both prior to and after chemotherapy. Nine of them did not express any P-glycoprotein before or after chemotherapy. However, one tumor expressed P-glycoprotein after six courses of multidrug resistance-related drug administration. These findings indicate that P-glycoprotein expression is not so common in ovarian tumors, regardless of their malignant potential. Nevertheless, the results suggest a strong association between P-glycoprotein expression and certain histological cell types in epithelial ovarian tumors. It is also possible that P-glycoprotein appears as a result of chemotherapy, but such a phenomenon can not occur unless chemotherapy is administered at high doses for a long period of time.</p>
キーワード P-glycoprotein epithelial ovarian tumor multidrug resistance immunohistochemistry
Amo Type Article
発行日 1994-10
出版物タイトル Acta Medica Okayama
48巻
5号
出版者 Okayama University Medical School
開始ページ 249
終了ページ 255
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
論文のバージョン publisher
査読 有り
PubMed ID 7863796
Web of Sience KeyUT A1994PP23600004